Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Dyne Therapeutics
Dyne Therapeutics
Three execs resign as Dyne posts mixed data for DMD candidate
Fierce Biotech
Tue, 09/3/24 - 05:56 pm
Dyne Therapeutics
DMD
DYNE-251
5 DMD Data Readouts to Watch in 2024
BioSpace
Mon, 05/6/24 - 11:24 am
DMD
clinical trials
Pfizer
gene therapy
fordadistrogene movaparvovec
Dyne Therapeutics
DYNE-251
Edgewise Therapeutics
EDG-5506
Capricor
CAP-1002
Avidity Biosciences
AOC 1044
Dyne's shares surge after promising data on muscle disorder treatment
Reuters
Wed, 01/3/24 - 09:33 am
Dyne Therapeutics
clinial trials
DYNE-101
myotonic muscular dystrophy
Duchenne Muscular Dystrophy
Another Duchenne clinical hold gets lifted, this time at Dyne Therapeutics
Endpoints
Tue, 07/5/22 - 10:45 am
Duchenne Muscular Dystrophy
clinical trials
Dyne Therapeutics
DYNE-251
Another huge quarter for biotech flotations
EP Vantage
Fri, 10/2/20 - 12:52 pm
biotech
IPOs
AlloVir
Relay Therapeutics
Nykarta
Dyne Therapeutics
Annexon Biosciences
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
Xconomy
Thu, 09/17/20 - 11:07 pm
Dyne Therapeutics
R&D
muscle disorders
Vida Ventures co-leads Dyne's $115M megaround for next-gen oligo therapies aimed squarely at muscles
Endpoints
Mon, 08/10/20 - 10:56 am
Dyne Therapeutics
oligo conjugates